Interpretation of biomonitoring data in clinical medicine and the exposure sciences
Bryan L Williams1, Dana B Barr, J Michael Wright
1University of Tennessee Health Science Center, Department of Pediatrics, Memphis, TN 38105, USA. bwilli36@utmem.edu
Abstract:
Biomonitoring has become a fundamental tool in both exposure science and clinical medicine. Despite significant analytical advances, the clinical use of environmental biomarkers remains in its infancy. Clinical use of environmental biomarkers poses some complex scientific and ethical challenges. The purpose of this paper is compare how the clinical and exposure sciences differ with respect to their interpretation and use of biological data. Additionally, the clinical use of environmental biomonitoring data is discussed. A case study is used to illustrate the complexities of conducting biomonitoring research on highly vulnerable populations in a clinical setting.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Therapeutic Drug Monitoring: Affecting Factors
Drug Concentrations: Measurements
Plasma —...
Therapeutic Drug Monitoring: Drug Analysis Methods
Bioequivalence Data: Statistical Interpretation
Measurement of Bioavailability: Pharmacokinetic Methods


